Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1997-9-2
|
pubmed:abstractText |
We found that simian virus 40 (SV40) induces mesotheliomas in hamsters and that 60% of human mesotheliomas contain and express SV40 sequences, results now confirmed by others [ref. 3-5, and presentations by D. Griffiths & R. Weiss, F. Galateau-SallE, and H.I.P. at "Simian virus 40: A possible human polyoma virus," NIH workshop, 27-28 January 1997, Bethesda, MD (transcript available through SAG Corp., Washington, DC 20008)]. Mesothelioma, an aggressive malignancy resistant to therapy, originates from the serosal lining of the pleural, pericardial and peritoneal cavities. The incidence of mesothelioma continues to increase worldwide because of exposure to crocidolite asbestos. However, at least 20% of mesotheliomas in the United States are not associated with asbestos exposure, and only a minority of people exposed to high concentrations of asbestos develop mesothelioma. Thus, other carcinogens may induce mesothelioma in individuals not exposed to asbestos, and/or may render particular individuals more susceptible to the carcinogenic effect of asbestos. We investigated whether the expression of the SV40 large T-antigen (Tag) interferes with the normal expression of the tumor suppressor gene p53 in human mesotheliomas. We found that SV40 Tag retains its ability to bind and to inactivate p53, a cellular protein that when normally expressed plays an important role in suppressing tumor growth and in inducing sensitivity to therapy. Our findings do not establish a cause-and-effect relation, but indicate that the possibility that SV40 contributes to the development of human mesotheliomas should be carefully investigated.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1078-8956
|
pubmed:author |
pubmed-author:CarboneMM,
pubmed-author:EspositoVV,
pubmed-author:GiordanoAA,
pubmed-author:GiulianoM TMT,
pubmed-author:GrimleyP MPM,
pubmed-author:LevineA SAS,
pubmed-author:LewE JEJ,
pubmed-author:PassH IHI,
pubmed-author:ProcopioAA,
pubmed-author:RizzoPP,
pubmed-author:ShridharVV,
pubmed-author:SteinbergS MSM,
pubmed-author:de BartolomeisAA
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
908-12
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9256284-Antigens, Polyomavirus Transforming,
pubmed-meshheading:9256284-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:9256284-Genes, p53,
pubmed-meshheading:9256284-Humans,
pubmed-meshheading:9256284-Immunohistochemistry,
pubmed-meshheading:9256284-Mesothelioma,
pubmed-meshheading:9256284-Mutation,
pubmed-meshheading:9256284-Pleural Neoplasms,
pubmed-meshheading:9256284-Protein Binding,
pubmed-meshheading:9256284-Simian virus 40,
pubmed-meshheading:9256284-Tumor Cells, Cultured,
pubmed-meshheading:9256284-Tumor Suppressor Protein p53
|
pubmed:year |
1997
|
pubmed:articleTitle |
Simian virus-40 large-T antigen binds p53 in human mesotheliomas.
|
pubmed:affiliation |
Cardinal Bernardin Cancer Center, Department of Pathology, Loyola University Chicago, Maywood, Illinois 60153, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|